Skip to Main Content

Author Details

Christopher Calabrese
St. Jude Children's Research Hospital
1997
37
25
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
30395907Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations.Cancer Lett2019
29248454Acquisition of Cholangiocarcinoma Traits during Advanced Hepatocellular Carcinoma Development in Mice.Am J Pathol2018
29301833Establishing a Preclinical Multidisciplinary Board for Brain Tumors.Clin Cancer Res2018
28522149Measuring Absolute Blood Perfusion in Mice Using Dynamic Contrast-Enhanced Ultrasound.Ultrasound Med Biol2017
28507546Extracellular Signal-Regulated Kinase Signaling in CD4-Expressing Cells Inhibits Osteochondromas.Front Immunol2017
28504719Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.Oncogene2017
26416771Maternal bile acid transporter deficiency promotes neonatal demise.Nat Commun2015
24395792Critical role for inflammasome-independent IL-1β production in osteomyelitis.Proc Natl Acad Sci U S A2014
25437539Targeting the DNA repair pathway in Ewing sarcoma.Cell Rep2014
25274309Dietary modulation of the microbiome affects autoinflammatory disease.Nature2014
23536557Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.Cancer Res2013
23788622Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunction.Genes Dev2013
22008912Preclinical dose-finding study with a liver-tropic, recombinant AAV-2/8 vector in the mouse model of galactosialidosis.Mol Ther2012
21263154Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia.Blood2011
21837651Magnetic resonance imaging-guided microdialysis cannula implantation in a spontaneous high-grade glioma murine model.J Pharm Sci2011
21559450Preclinical models for neuroblastoma: establishing a baseline for treatment.PLoS One2011
21487100Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia.J Natl Cancer Inst2011
20338480Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation.Int J Radiat Oncol Biol Phys2010
20460504Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas.Cancer Res2010
20177071Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis.J Biol Chem2010
18240294A modified surgical procedure for microdialysis probe implantation in the lateral ventricle of a FVB mouse.J Pharm Sci2008
17222791A perivascular niche for brain tumor stem cells.Cancer Cell2007
17579115Continuous delivery of IFN-beta promotes sustained maturation of intratumoral vasculature.Mol Cancer Res2007
17363588Genetic alterations in mouse medulloblastomas and generation of tumors de novo from primary cerebellar granule neuron precursors.Cancer Res2007
17363489Preclinical selection of a novel poly(ADP-ribose) polymerase inhibitor for clinical trial.Mol Cancer Ther2007
16260494The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.Genes Dev2005
16226707Radial glia cells are candidate stem cells of ependymoma.Cancer Cell2005
14709739Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361.J Natl Cancer Inst2004
15481984Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase.J Med Chem2004
12517790ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma.Cancer Res2003
12709419Medulloblastoma sensitivity to 17-allylamino-17-demethoxygeldanamycin requires MEK/ERKM.J Biol Chem2003
12855651Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies.Clin Cancer Res2003
12408707Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: design, synthesis, and X-ray cocrystal structure.J Med Chem2002
11817028Separation methods for anthraquinone related anti-cancer drugs.J Chromatogr B Biomed Sci Appl2001
9929509In vivo metabolism of the antitumor imidazoacridinone C1311 in the mouse and in vitro comparison with humans.Drug Metab Dispos1999
9771952Pharmacokinetics and tissue distribution of the imidazoacridinone C1311 in tumour-bearing mice.Cancer Chemother Pharmacol1998
9106053Analysis of the imidazoacridinone C1311 by high-performance liquid chromatography.J Chromatogr B Biomed Sci Appl1997
  • 1 - 37 of 37

Recommended Authors

Goldfinch Bio Inc.
Career Start Year 2007
Number of shared co-authors 0
Ontario Institute for Cancer Research, University Avenue
Career Start Year 2007
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
Queen's University
Career Start Year 2006
Number of shared co-authors 0
Sino-French Hoffmann Institute, Guangzhou Medical University
Career Start Year 2003
Number of shared co-authors 6
Novartis Institutes for BioMedical Research
Career Start Year 2003
Number of shared co-authors 2
Oncology R&D
Career Start Year 2001
Number of shared co-authors 0
Steadman Philippon Research Institute, Center for Regenerative Sports Medicine
Career Start Year 2001
Number of shared co-authors 0
Instituto de Investigaciones Biomedicas "Alberto Sols"
Career Start Year 2001
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 0
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 2
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 1
Brody School of Medicine, East Carolina University
Career Start Year 1997
Number of shared co-authors 0
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
St. Jude Children's Research Hospital.
Career Start Year 1992
Number of shared co-authors 8
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Departamento de Toxicologia y Farmacologia Preclinica
Career Start Year 1989
Number of shared co-authors 0
Department of Pharmaceutical Sciences, Utrecht University
Career Start Year 1987
Number of shared co-authors 2
Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine
Career Start Year 1987
Number of shared co-authors 2
Clinical Research Division, Fred Hutchinson Cancer Center
Career Start Year 1985
Number of shared co-authors 22
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1977
Number of shared co-authors 1
Institute of Biomedical Engineering (IBME), University of Oxford
Career Start Year 1976
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1975
Number of shared co-authors 0
The Institute of Cancer Research
Career Start Year 1974
Number of shared co-authors 5
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 1
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 3
The University of Texas Health Science Center at San Antonio
Career Start Year 1971
Number of shared co-authors 16

Collaborators

Cancer Research UK Cambridge Institute, University of Cambridge
Co-authored papers 9
St. Jude Children's Research Hospital
Co-authored papers 8
St. Jude Children's Research Hospital
Co-authored papers 4
St. Jude Children's Research Hospital
Co-authored papers 4
St. Jude Children's Research Hospital
Co-authored papers 3
St. Jude Children's Research Hospital
Co-authored papers 3
St. Jude Children's Research Hospital
Co-authored papers 3
AbbVie Inc.
Co-authored papers 2
Co-authored papers 2
St Jude Children's Research Hospital
Co-authored papers 2
St. Jude Children's Research Hospital
Co-authored papers 2
Co-authored papers 2
Medical University of South Carolina
Co-authored papers 2
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 1
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Ohio State University
Co-authored papers 1
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 1
St. Jude Children's Research Hospital
Co-authored papers 1
St. Jude Children's Research Hospital
Co-authored papers 1
Departments of Pharmaceutical Sciences.
Co-authored papers 1
St. Jude Children's Research Hospital.
Co-authored papers 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 1
University of Wisconsin-Madison School of Medicine and Public Health
Co-authored papers 1
University of California-San Diego
Co-authored papers 1
Co-authored papers 1
Institute of Pathology, Kings County Hospital Center
Co-authored papers 1
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 1
Institut Curie, PSL Research University, CNRS UMR, INSERM
Co-authored papers 1
The Ohio State University
Co-authored papers 1